Patents by Inventor Robert Soliva Soliva

Robert Soliva Soliva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8901146
    Abstract: Aminoalkylpyrimidine derivatives of formula I, wherein the meaning of the different substituents are those indicated in the description. These compounds are useful as histamine H4 receptor antagonists.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: December 2, 2014
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Elena Carceller Gonzalez, Marina Virgili Bernado, Robert Soliva Soliva, Carles Ferrer Costa
  • Publication number: 20130289015
    Abstract: N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors.
    Type: Application
    Filed: June 28, 2013
    Publication date: October 31, 2013
    Inventors: Carmen Almansa Rosales, Jorge Salas Solana, Robert Soliva Soliva, Sergio Rodriguez Escrich, Maria Cristina Sicre Gonzalez
  • Patent number: 8501735
    Abstract: N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: August 6, 2013
    Assignee: Palau Pharma, S.A.
    Inventors: Carmen Almansa Rosales, Jorge Salas Solana, Robert Soliva Soliva, Sergio Rodriguez Escrich, Maria Cristina Sicre González
  • Publication number: 20130131038
    Abstract: N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors.
    Type: Application
    Filed: October 29, 2010
    Publication date: May 23, 2013
    Inventors: Carmen Almansa Rosales, Jorge Salas Solana, Robert Soliva Soliva, Sergio Rodríguez Escrich, Maria Cristina Sicre Gonzåles
  • Patent number: 8431580
    Abstract: 4-Aminopyrimidine derivatives of formula (I) that are useful as histamine H4 receptor antagonists.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: April 30, 2013
    Assignee: Palau Pharma, S.A.
    Inventors: Elena Carceller González, Eva Maria Medina Fuentes, Robert Soliva Soliva, Marina Virgili Bernadó, Josep Martí Via
  • Publication number: 20130018031
    Abstract: Aminoalkylpyrimidine derivatives of formula I, wherein the meaning of the different substituents are those indicated in the description. These compounds are useful as histamine H4 receptor antagonists.
    Type: Application
    Filed: December 22, 2010
    Publication date: January 17, 2013
    Applicant: MEDICIS PHARMACEUTICAL CORPORATION
    Inventors: Elena Carceller Gonzalez, Marina Virgili Bernado, Robert Soliva Soliva, Carles Ferrer Costa
  • Publication number: 20120245140
    Abstract: N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors.
    Type: Application
    Filed: October 29, 2010
    Publication date: September 27, 2012
    Inventors: Carmen Almansa Rosales, Jorge Salas Solana, Robert Soliva Soliva, Sergio Rodríguez Escrich, Maria Cristina Sicre Gonzåles
  • Publication number: 20110160185
    Abstract: Pyrrolopyrimidine derivatives of Formula (I) that are useful as JAK3 kinase inhibitors.
    Type: Application
    Filed: March 31, 2008
    Publication date: June 30, 2011
    Inventors: Jorge Salas Solana, Carmen Almansa Rosales, Robert Soliva Soliva, Montserrat Fontes Ustrell, Marc Vendrell Escobar
  • Publication number: 20110039817
    Abstract: 4-Aminopyrimidine derivatives of formula (I) that are useful as histamine H4 receptor antagonists.
    Type: Application
    Filed: December 18, 2008
    Publication date: February 17, 2011
    Inventors: Elena Carceller González, Eva María Medina Fuentes, Robert Soliva Soliva, Marina Virgili Bernadó, Josep Martí Via
  • Publication number: 20100204187
    Abstract: Purine derivatives of Formula (I), wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK3 kinase inhibitors.
    Type: Application
    Filed: January 23, 2008
    Publication date: August 12, 2010
    Inventors: Jorge Salas Solana, Carmen Almansa Rosales, Robert Soliva Soliva, Montserrat Fontes Ustrell, Marina Virgili Bernadó, Josep Comelles Espuga, José Javier Pastor Porras
  • Publication number: 20100113420
    Abstract: Pyrrolopyrimidine derivatives of Formula (I) that are useful as JAK3 kinase inhibitors.
    Type: Application
    Filed: March 31, 2008
    Publication date: May 6, 2010
    Inventors: Jorge Salas Solana, Carmen Almansa Rosales, Robert Soliva Soliva, Montserrat Fontes Ustrell, Marc Vendrell Escobar
  • Publication number: 20090306038
    Abstract: 2-Aminopyrimidine derivatives of formula (I) that are useful as modulators of the H4 receptor.
    Type: Application
    Filed: September 12, 2006
    Publication date: December 10, 2009
    Inventors: Elena Carceller González, Jorge Salas Solana, Robert Soliva Soliva, Eva Maria Medina Fuentes, Josep Marti Via